Taken together, these observations suggest that ACOXL‐driven perturbations of lipid catabolism may couple metabolic reprogramming to apoptosis resistance and immune evasion within the gastric tumor microenvironment, providing a mechanistic context for its adverse prognostic association. The gene discussed is ACOXL; the disease is gastric neoplasm.